Hypoxia-inducible factor regulates osteoclast-mediated bone resorption: Role of angiopoietin-like 4

FASEB Journal

Volumn 24, Issue 12, 2010, Pages 4648-4659

  Knowles, Helen J ^a   Cleton Jansen, Anne Marie ^c   Korsching, Eberhard ^d   Athanasou, Nicholas A ^b  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^d UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

Differentiation; Osteoblast; Osteoclastogenesis; Pathological bone resorption; Proliferation

Indexed keywords

ANGIOPOIETIN; ANGIOPOIETIN LIKE 4; DEFEROXAMINE; HYPOXIA INDUCIBLE FACTOR; MIMOSINE; UNCLASSIFIED DRUG;

ARTICLE; CELL FUNCTION; CELL PROLIFERATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; MONOCYTE; OSTEOBLAST; OSTEOCLAST; OSTEOLYSIS; PRIORITY JOURNAL;

ANGIOPOIETINS; BLOTTING, WESTERN; BONE RESORPTION; CELL DIFFERENTIATION; CELL LINE; CELL PROLIFERATION; CELLS, CULTURED; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; IMMUNOHISTOCHEMISTRY; OSTEOCLASTS; POLYMERASE CHAIN REACTION; RNA, SMALL INTERFERING;

EID: 78649722176     PISSN: 08926638     EISSN: 15306860     Source Type: Journal    
DOI: 10.1096/fj.10-162230     Document Type: Article

References (64)

1. Epstein, A. C., Gleadle, J. M., McNeill, L. A., Hewitson, K. S., O'Rourke, J., Mole, D. R., Mukherji, M., Metzen, E., Wilson, M. I., Dhanda, A., Tian, Y. M., Masson, N., Hamilton, D. L., Jaakkola, P., Barstead, R., Hodgkin, J., Maxwell, P. H., Pugh, C. W., Schofield, C. J., and Ratcliffe, P. J. (2001) C. elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation. Cell 107, 43-54
2. Bruick, R. K., and McKnight, S. L. (2001) A conserved family of prolyl-4-hydroxylases that modify HIF. Science 294, 1337-1340
3. Harris, A. L. (2002) Hypoxia - a key regulatory factor in tumour growth. Nat. Rev. Cancer 2, 38-47
4. Wang, Y., Wan, C., Deng, L., Liu, X., Cao, X., Gilbert, S. R., Bouxsein, M. L., Faugere, M. C., Guldberg, R. E., Gerstenfeld, L. C., Haase, V. H., Johnson, R. S., Schipani, E., and Clemens, T. L. (2007) The hypoxia-inducible factor alpha pathway couples angiogenesis to osteogenesis during skeletal development. J. Clin. Invest. 117, 1616-1626
5. Wan, C., Gilbert, S. R., Wang, Y., Cao, X., Shen, X., Ramaswamy, G., Jacobsen, K. A., Alaql, Z. S., Eberhardt, A. W., Gerstenfeld, L. C., Einhorn, T. A., Deng, L., and Clemens, T. L. (2008) Activation of the hypoxia-inducible factor-1α pathway accelerates bone regeneration. Proc. Natl. Acad. Sci. U. S. A. 105, 686-691
6. Shomento, S. H., Wan, C., Cao, X., Faugere, M. C., Bouxsein, M. L., Clemens, T. L., and Riddle, R. C. (2010) Hypoxia-inducible factors 1α and 2α exert both distinct and overlapping functions in long bone development. J. Cell. Biochem. 109, 196-204
7. Shen, X., Wan, C., Ramaswamy, G., Mavalli, M., Wang, Y., Duvall, C. L., Deng, L. F., Guldberg, R. E., Eberhart, A., Clemens, T. L., and Gilbert, S. R. (2009) Prolyl hydroxylase inhibitors increase neoangiogenesis and callus formation following femur fracture in mice. J. Orthop. Res. 27, 1298-1305
8. Komatsu, D. E., Bosch-Marce, M., Semenza, G. L., and Hadjiargyrou, M. (2007) Enhanced bone regeneration associated with decreased apoptosis in mice with partial HIF-1α deficiency. J. Bone Miner. Res. 22, 366-374
9. Knowles, H. J., and Athanasou, N. A. (2009) Acute hypoxia and osteoclast activity: a balance between enhanced resorption and increased apoptosis. J. Pathol. 218, 256-264
10. Arnett, T. R., Gibbons, D. C., Utting, J. C., Orriss, I. R., Hoebertz, A., Rosendaal, M., and Meghji, S. (2003) Hypoxia is a major stimulator of osteoclast formation and bone resorption. J. Cell. Physiol. 196, 2-8
11. Muzylak, M., Price, J. S., and Horton, M. A. (2006) Hypoxia induces giant osteoclast formation and extensive bone resorption in the cat. Calcif. Tissue Int. 79, 301-309
12. Bozec, A., Bakiri, L., Hoebertz, A., Eferl, R., Schilling, A. F., Komnenovic, V., Scheuch, H., Priemel, M., Stewart, C. L., Amling, M., and Wagner, E. F. (2008) Osteoclast size is controlled by Fra-2 through LIF/LIF-receptor signalling and hypoxia. Nature 454, 221-225
13. Kersten, S., Mandard, S., Tan, N. S., Escher, P., Metzger, D., Chambon, P., Gonzalez, F. J., Desvergne, B., and Wahli, W. (2000) Characterization of the fasting-induced adipose factor FIAF, a novel peroxisome proliferator-activated receptor target gene. J. Biol. Chem. 275, 28488-28493
14. Yoon, J. C., Chickering, T. W., Rosen, E. D., Dussault, B., Qin, Y. B., Soukas, A., Friedman, J. M., Holmes, W. E., and Spiegelman, B. M. (2000) Peroxisome proliferator-activated receptor γ target gene encoding a novel angiopoietin-related protein associated with adipose differentiation. Mol. Cell. Biol. 20, 5343-5349
15. Kim, I., Kim, H. G., Kim, H., Kim, H. H., Park, S. K., Uhm, C. S., Lee, Z. H., and Koh, G. Y. (2000) Hepatic expression, synthesis and secretion of a novel fibrinogen/angiopoietin-related protein that prevents endothelial-cell apoptosis. Biochem. J. 346, 603-610
16. Mandard, S., Zandbergen, F., Tan, N. S., Escher, P., Patsouris, D., Koenig, W., Kleemann, R., Bakker, A., Veenman, F., Wahli, W., Muller, M., and Kersten, S. (2004) The direct peroxisome proliferator-activated receptor target fasting-induced adipose factor (FIAF/PGAR/ANGPTL4) is present in blood plasma as a truncated protein that is increased by fenofibrate treatment. J. Biol. Chem. 279, 34411-34420
17. Belanger, A. J., Lu, H. W., Date, L., Liu, L. X., Vincent, K. A., Akita, G. Y., Cheng, S. H., Gregory, R. J., and Jiang, C. W. (2002) Hypoxia up-regulates expression of peroxisome proliferator-activated receptor gamma angiopoietin-related gene (PGAR) in cardiomyocytes: role of hypoxia inducible factor 1 α. J. Mol. Cell. Cardiol. 34, 765-774
18. Warnecke, C., Weidemann, A., Volke, M., Schietke, R., Wu, X. Q., Knaup, K. X., Hackenbeck, T., Bernhardt, W., Willam, C., Eckardt, K. U., and Wiesener, M. S. (2008) The specific contribution of hypoxia-inducible factor-2α to hypoxic gene expression in vitro is limited and modulated by cell type-specific and exogenous factors. Exp. Cell Res. 314, 2016-2027
19. Wang, B., Wood, I. S., and Trayhurn, P. (2007) Dysregulation of the expression and secretion of inflammation-related adipokines by hypoxia in human adipocytes. Pflügers Arch. 455, 479-492 (Pubitemid 47624196)
20. Le Jan, S., Amy, C., Cazes, A., Monnot, C., Lamande, N., Favier, J., Philippe, J., Sibony, M., Gasc, J. M., Corvol, P., and Germain, S. (2003) Angiopoietin-like 4 is a proangiogenic factor produced during ischemia and in conventional renal cell carcinoma. Am. J. Pathol. 162, 1521-1528
21. Murata, M., Yudo, K., Nakamura, H., Chiba, J., Okamoto, K., Suematsu, N., Nishioka, K., Beppu, M., Inoue, K., Kato, T., and Masuko, K. (2009) Hypoxia upregulates the expression of angiopoietin-like-4 in human articular chondrocytes: role of angiopoietin-like-4 in the expression of matrix metalloproteinases and cartilage degradation. J. Orthop. Res. 27, 50-57
22. Joyner, C. J., Quinn, J. M., Triffitt, J. T., Owen, M. E., and Athanasou, N. A. (1992) Phenotypic characterisation of mononuclear and multinucleated cells of giant cell tumour of bone. Bone Miner. 16, 37-48
23. Lau, Y. S., Sabokbar, A., Gibbons, C. L., Giele, H., and Athanasou, N. (2005) Phenotypic and molecular studies of giant-cell tumors of bone and soft tissue. Hum. Pathol. 36, 945-954
24. Hallor, K. H., Staaf, J., Bovee, J., Hogendoorn, P. C. W., Cleton-Jansen, A. M., Knuutila, S., Savola, S., Niini, T., Brosjo, O., Bauer, H. C. F., von Steyern, F. V., Jonsson, K., Skorpil, M., Mandahl, N., and Mertens, F. (2009) Genomic profiling of chondrosarcoma: chromosomal patterns in central and peripheral tumors. Clin. Cancer Res. 15, 2685-2694
25. Seitz, S., Korsching, E., Weimer, J., Jacobsen, A., Arnold, N., Meindl, A., Arnold, W., Gustavus, D., Klebig, C., Petersen, I., and Scherneck, S. (2006) Genetic background of different cancer cell lines influences the gene set involved in chromosome 8 mediated breast tumor suppression. Genes Chromosomes Cancer 45, 612-627
26. Tusher, V. G., Tibshirani, R., and Chu, G. (2001) Significance analysis of microarrays applied to the ionizing radiation response. Proc. Natl. Acad. Sci. U. S. A. 98, 5116-5121
27. Sowter, H. M., Raval, R. R., Moore, J. W., Ratcliffe, P. J., and Harris, A. L. (2003) Predominant role of hypoxia-inducible transcription factor (Hif)-1α versus Hif-2α in regulation of the transcriptional response to hypoxia. Cancer Res. 63, 6130-6134
28. Gregory, C. A., Gunn, W. G., Peister, A., and Prockop, D. J. (2004) An alizarin red-based assay of mineralization by adherent cells in culture: comparison with cetylpyridinium chloride extraction. Anal. Biochem. 329, 77-84
29. Wiesener, M. S., Turley, H., Allen, W. E., Willam, C., Eckardt, K. U., Talks, K. L., Wood, S. M., Gatter, K. C., Harris, A. L., Pugh, C. W., Ratcliffe, P. J., and Maxwell, P. H. (1998) Induction of endothelial PAS domain protein-1 by hypoxia: characterization and comparison with hypoxia-inducible factor-1α. Blood 92, 2260-2268
30. Knowles, H. J., and Athanasou, N. A. (2008) Hypoxia-inducible factor is expressed in giant cell tumour of bone and mediates paracrine effects of hypoxia on monocyte-osteoclast differentiation via induction of VEGF. J. Pathol. 215, 56-66
31. Gaber, T., Dziurla, R., Tripmacher, R., Burmester, G. R., and Buttgereit, F. (2005) Hypoxia inducible factor (HIF) in rheumatology: low O2! See what HIF can do! Ann. Rheum. Dis. 64, 971-980
32. Patntirapong, S., Habibovic, P., and Hauschka, P. V. (2009) Effects of soluble cobalt and cobalt incorporated into calcium phosphate layers on osteoclast differentiation and activation. Biomaterials 30, 548-555
33. Kurosaka, D., Yoshida, K., Yasuda, J., Yokoyama, T., Kingetsu, I., Yamaguchi, N., Joh, K., Matsushima, M., Saito, S., and Yamada, A. (2003) Inhibition of arthritis by systemic administration of endostatin in passive murine collagen induced arthritis. Ann. Rheum. Dis. 62, 677-679
34. Cramer, T., Yamanishi, Y., Clausen, B. E., Forster, I., Pawlinski, R., Mackman, N., Haase, V. H., Jaenisch, R., Corr, M., Nizet, V., Firestein, G. S., Gerber, H. P., Ferrara, N., and Johnson, R. S. (2003) HIF-1α is essential for myeloid cell-mediated inflammation. Cell 112, 645-657
35. Cazes, A., Galaup, A., Chomel, C., Bignon, M., Brechot, N., Le Jan, S., Weber, H., Corvol, P., Muller, L., Germain, S., and Monnot, C. (2006) Extracellular matrix-bound angiopoietinlike 4 inhibits endothelial cell adhesion, migration, and sprouting and alters actin cytoskeleton. Circ. Res. 99, 1207-1215
36. Chomel, C., Cazes, A., Faye, C., Bignon, M., Gomez, E., Ardidie- Robouant, C., Barret, A., Ricard-Blum, S., Muller, L., Germain, S., and Monnot, C. (2009) Interaction of the coiled-coil domain with glycosaminoglycans protects angiopoietin-like 4 from proteolysis and regulates its antiangiogenic activity. FASEB J. 23, 940-949
37. Hermann, L. M., Pinkerton, M., Jennings, K., Yang, L., Grom, A., Sowders, D., Kersten, S., Witte, D. P., Hirsch, R., and Thornton, S. (2005) Angiopoietin-like-4 is a potential angiogenic mediator in arthritis. Clin. Immunol. 115, 93-101
38. Hu, Z. Y., Fan, C., Livasy, C., He, X. P., Oh, D. S., Ewend, M. G., Carey, L. A., Subramanian, S., West, R., Ikpatt, F., Olopade, O. I., van de Rijn, M., and Perou, C. M. (2009) A compact VEGF signature associated with distant metastases and poor outcomes. BMC Med. 7, 14
39. Xia, K., Xue, H. L., Dong, D., Zhu, S. S., Wang, J. M., Zhang, Q. P., Hou, L., Chen, H., Tao, R., Huang, Z., Fu, Z., Chen, Y. G., and Han, J. D. J. (2006) Identification of the proliferation/ differentiation switch in the cellular network of multicellular organisms. PLoS Comput. Biol. 2, 1482-1497
40. Pan, B. Q., To, L. B., Farrugia, A. N., Findlay, D. M., Green, J., Gronthos, S., Evdokiou, A., Lynch, K., Atkins, G. J., and Zannettino, A. C. W. (2004) The nitrogen-containing bisphosphonate, zoledronic acid, increases mineralisation of human bone-derived cells in vitro. Bone 34, 112-123
41. Fuller, K., Kirstein, B., and Chambers, T. J. (2007) Regulation and enzymatic basis of bone resorption by human osteoclasts. Clin. Sci. 112, 567-575
42. Yang, Y. H., Wang, Y., Lam, K. S., Yau, M. H., Cheng, K. K., Zhang, J., Zhu, W., Wu, D., and Xu, A. (2008) Suppression of the Raf/MEK/ERK signaling cascade and inhibition of angiogenesis by the carboxyl terminus of angiopoietin-like protein 4. Arterioscler. Thrombosis Vasc. Biol. 28, 835-840
43. 3 and induces blood vessel formation in vivo. J. Biol. Chem. 277, 17281-17290
44. Hato, T., Tabata, M., and Oike, Y. (2008) The role of angiopoietin-like proteins in angiogenesis and metabolism. Trends Cardiovasc. Med. 18, 6-14
45. Teitelbaum, S. L., and Ross, F. P. (2003) Genetic regulation of osteoclast development and function. Nat. Rev. Genet. 4, 638-649
46. Franceschi, R. T. (1999) The developmental control of osteoblast- specific gene expression: role of specific transcription factors and the extracellular matrix environment. Crit. Rev. Oral Biol. Med. 10, 40-57
47. Ito, Y., Oike, Y., Yasunaga, K., Hamada, K., Miyata, K., Matsumoto, S., Sugano, S., Tanihara, H., Masuho, Y., and Suda, T. (2003) Inhibition of angiogenesis and vascular leakiness by angiopoietin-related protein 4. Cancer Res. 63, 6651-6657
48. Galaup, A., Cazes, A., Le Jan, S., Philippe, J., Connault, E., Le Coz, E., Mekid, H., Mir, L. M., Opolon, P., Corvol, P., Monnot, C., and Germain, S. (2006) Angiopoietin-like 4 prevents metastasis through inhibition of vascular permeability and tumor cell motility and invasiveness. Proc. Natl. Acad. Sci. U. S. A. 103, 18721-18726
49. Mandard, S., Zandbergen, F., van Straten, E., Wahli, W., Kuipers, F., Muller, M., and Kersten, S. (2006) The fasting-induced adipose factor/angiopoietin-like protein 4 is physically associated with lipoproteins and governs plasma lipid levels and adiposity. J. Biol. Chem. 281, 21575-21575
50. Adachi, H., Fujiwara, Y., Kondo, T., Nishikawa, T., Ogawa, R., Matsumura, T., Ishii, N., Nagai, R., Miyata, K., Tabata, M., Motoshima, H., Furukawa, N., Tsuruzoe, K., Kawashima, J., Takeya, M., Yamashita, S., Koh, G. Y., Nagy, A., Suda, T., Oike, Y., and Araki, E. (2009) Angptl 4 deficiency improves lipid metabolism, suppresses foam cell formation and protects against atherosclerosis. Biochem. Biophys. Res. Commun. 379, 806-811
51. Li, C. (2006) Genetics and regulation of angiopoietin-like proteins 3 and 4. Curr. Opin. Lipidol. 17, 152-156
52. Pajvani, U. B., Du, X. L., Combs, T. P., Berg, A. H., Rajala, M. W., Schulthess, T., Engel, J., Brownlee, M., and Scherer, P. E. (2003) Structure-function studies of the adipocyte-secreted hormone Acrp30/adiponectin - Implications for metabolic regulation and bioactivity. J. Biol. Chem. 278, 9073-9085
53. Patel, S. D., Rajala, M. W., Rossetti, L., Scherer, P. E., and Shapiro, L. (2004) Disulfide-dependent multimeric assembly of resistin family hormones. Science 304, 1154-1158
54. Aderka, D., Le, J. M., and Vilcek, J. (1989) IL-6 inhibits lipopolysaccharide-induced tumour necrosis factor production in human monocytes, U937 cells, and in mice. J. Immunol. 143, 3517-3523
55. Gearing, A. J. H., Beckett, P., Christodoulou, M., Churchill, M., Clements, J., Davidson, A. H., Drummond, A. H., Galloway, W. A., Gilbert, R., Gordon, J. L., Leber, T. M., Mangan, M., Miller, K., Nayee, P., Owen, K., Patel, S., Thomas, W., Wells, G., Wood, L. M., and Woolley, K. (1994) Processing of tumour necrosis factor alpha precursor by metalloproteinases. Nature 370, 555-557
56. Knowles, H. J., and Athanasou, N. A. (2009) Canonical and non-canonical pathways of osteoclast formation. Histol. Histopathol. 24, 337-346
57. Thommesein, L., Stunes, A. K., Monjo, M., Grosvik, K., Tamburstuen, M. V., Kjobli, E., Lyngstadaas, S. P., Reseland, J. E., and Syversen, U. (2006) Expression and regulation of resistin in osteoblasts and osteoclasts indicate a role in bone metabolism. J. Cell. Biochem. 99, 824-834
58. Cornish, J., Callon, K. E., Watson, M., Lin, J. M., and Reid, I. R. (2006) Resistin, an adipocytokine, stimulates osteoblast and osteoclast proliferation. Bone 38, S9-S9
59. Berner, H. S., Lyngstadaas, S. P., Spahr, A., Monjo, M., Thommesen, L., Drevon, C. A., Syversen, U., and Reseland, J. E. (2004) Adiponectin and its receptors are expressed in bone-forming cells. Bone 35, 842-849
60. Oshima, K., Nampei, A., Matsuda, M., Iwaki, M., Fukuhara, A., Hashimoto, J., Yoshikawa, H., and Shimomura, I. (2005) Adiponectin increases bone mass by suppressing osteoclast and activating osteoblast. Biochem. Biophys. Res. Commun. 331, 520-526
61. Luo, X. H., Guo, L. J., Xie, H., Yuan, L. Q., Wu, X. P., Zhou, H. D., and Liao, E. Y. (2006) Adiponectin stimulates RANKL and inhibits OPG expression in human osteoblasts through the MAPK signaling pathway. J. Bone Miner. Res. 21, 1648-1656
62. Reid, I. R. (2008) Relationships between fat and bone. Osteoporos. Int. 19, 595-606
63. Wan, Y. H., Chong, L. W., and Evans, R. M. (2007) PPAR-γ regulates osteoclastogenesis in mice. Nat. Med. 13, 1496-1503
64. Grey, A. (2008) Skeletal consequences of thiazolidinedione therapy. Osteoporos. Int. 19, 129-137